1. Home
  2. AVTX vs ASMB Comparison

AVTX vs ASMB Comparison

Compare AVTX & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • ASMB
  • Stock Information
  • Founded
  • AVTX 2011
  • ASMB 2005
  • Country
  • AVTX United States
  • ASMB United States
  • Employees
  • AVTX N/A
  • ASMB N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVTX Health Care
  • ASMB Health Care
  • Exchange
  • AVTX Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • AVTX 88.4M
  • ASMB 92.1M
  • IPO Year
  • AVTX 2015
  • ASMB 2010
  • Fundamental
  • Price
  • AVTX $8.18
  • ASMB $13.42
  • Analyst Decision
  • AVTX Strong Buy
  • ASMB Buy
  • Analyst Count
  • AVTX 4
  • ASMB 2
  • Target Price
  • AVTX $33.00
  • ASMB $35.00
  • AVG Volume (30 Days)
  • AVTX 64.7K
  • ASMB 22.9K
  • Earning Date
  • AVTX 03-28-2025
  • ASMB 03-27-2025
  • Dividend Yield
  • AVTX N/A
  • ASMB N/A
  • EPS Growth
  • AVTX N/A
  • ASMB N/A
  • EPS
  • AVTX N/A
  • ASMB N/A
  • Revenue
  • AVTX $820,000.00
  • ASMB $28,326,000.00
  • Revenue This Year
  • AVTX N/A
  • ASMB $282.16
  • Revenue Next Year
  • AVTX N/A
  • ASMB N/A
  • P/E Ratio
  • AVTX N/A
  • ASMB N/A
  • Revenue Growth
  • AVTX N/A
  • ASMB N/A
  • 52 Week Low
  • AVTX $4.18
  • ASMB $11.01
  • 52 Week High
  • AVTX $34.46
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 52.50
  • ASMB 40.25
  • Support Level
  • AVTX $7.82
  • ASMB $13.60
  • Resistance Level
  • AVTX $8.50
  • ASMB $14.25
  • Average True Range (ATR)
  • AVTX 0.78
  • ASMB 0.58
  • MACD
  • AVTX 0.20
  • ASMB -0.05
  • Stochastic Oscillator
  • AVTX 73.11
  • ASMB 5.93

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: